The pharmacy contract for 2026/2027 has been delayed, according to the report published in March 2026. The delay affects the planned updates to community pharmacy services and funding structures for the upcoming year. No specific reason for the postponement was provided in the announcement.
The contract, which typically outlines payment rates, service obligations, and operational guidelines for pharmacies, is a critical document for the sector. It could impact planning for individual pharmacies and broader industry stakeholders who depend on its terms to allocate resources and staff.
Other developments in the pharmacy sector during March 2026 include the election of a new president for the Royal College of Pharmacy and reports highlighting issues such as racism, threats, and violence against pharmacy teams. Drug price concessions also reached a three-year high, according to the same report.
Other ongoing challenges in the sector include medicines shortages and debates over pharmacogenomics prescribing resources. The Royal College of Pharmacy has called for responsible pharmacist requirements to adapt to evolving practice demands, though concerns remain that additional mandates could complicate pharmacy operations.
Industry stakeholders have urged clarity on the revised timeline for the contract, particularly as pharmacies prepare for seasonal demand fluctuations and regulatory changes.
These reductions help offset operational costs, though they may also impact revenue projections.